CRT-D & ICD Device Clinical Data

OUTLASTING THE COMPETITION

Nine recent clinical studies with over 11,314 patients show that devices with EnduraLife™ Battery Technology are lasting longer than comparable devices from both Medtronic and St. Jude Medical.^1-9

Customized Longevity
Comparison

CRT-D Survival Data

Chart: 6 Year 4 Year CRT-D Survival Data

Filter By

All (-)

Sort By

Newest A - Z

2013 Saba Trial

PDF( 364.0 KB )

This 6-year follow-up study shows divergence in battery longevity between Boston Scientific and St. Jude Medical beginning around year 5, with Boston Scientific having significantly higher device survival rate for CRT-D devices through year 6.
2014 Williams Trial

PDF( 198.0 KB )

Explore the results of an independent, retrospective observational study comparing battery longevity of contemporary CRT-Ds. The results are from a non-academic community hospital (NCH), which may have substantial differences in age, gender and comorbidities than those in academic centers and national trials.
2014 Ellis Trial

PDF( 223.0 KB )

A multi-center, retrospective observational study with data collected from 710 patients showed that battery capacity (Ah) is a useful predictor of device longevity, and Boston Scientific devices, with a usable battery capacity of 2.0 Ah, last significantly longer than Medtronic or St. Jude Medical devices.
2014 Johansen Trial

PDF( 197.0 KB )

This independent, retrospective observational study comparing battery longevity of contemporary CRT-Ds of patients implanted with CRT-ICDs from January 1, 2007, to October 31, 2013, found that Boston Scientific CRT-Ds last significantly longer than Medtronic CRT-Ds.
2015 Lau Trial

PDF( 208.0 KB )

See the results of this independent, retrospective observational study comparing battery longevity of contemporary cardiac resynchronization therapy defibrillators (CRT-Ds) of all patients implanted with CRT-ICDs from 2008 through 2009 at Royal Victoria Hospital in Belfast, Northern Ireland.
2015 Landolina Trial

PDF( 216.0 KB )

This independent, retrospective observational study comparing battery longevity of contemporary cardiac resynchronization therapy defibrillators (CRT-D) found that Boston Scientific’s modern CRT-Ds have the lowest risk of replacement at 5 years.
2016 Schaer/Von Gunten Trial

PDF( 353.0 KB )

The largest study to investigate multiple manufacturer ICD longevity to date, conducted with data from two large European centers, confirms Boston Scientific as the longevity leader across VR, DR and CRT ICDs.